Cours Escalon Medical Corp. Other OTC
Actions
ESMC
US2960743050
Equipement et technologie médicale avancés
CA 2022 | 10,7 M 9,52 M | CA 2023 | 12,18 M 10,84 M | Capitalisation | 1,85 M 1,65 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 0,14 x |
Dette nette 2022 | 611 k 544 k | Dette nette 2023 | 205 182,43 | VE / CA 2023 | 0,15 x |
PER 2022 |
-28
x | PER 2023 |
8,37
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 98,1% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 01/11/00 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 01/01/97 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 01/01/03 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 01/11/00 |
David Jacovini
BRD | Director/Board Member | 48 | 13/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+7,32% | 217 Md | |
+13,83% | 194 Md | |
+20,48% | 143 Md | |
+31,33% | 111 Md | |
+3,08% | 64,3 Md | |
+14,64% | 52,94 Md | |
+2,72% | 49,53 Md | |
-5,88% | 38,31 Md | |
+0,25% | 35,22 Md |